HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.

AbstractPURPOSE:
To retrospectively evaluate the technical and clinical outcomes of superior vena cava (SVC) stent placement through upper-limb venous access in malignant SVC syndrome (SVCS) and compare the efficacy of different nitinol stent types.
MATERIALS AND METHODS:
Between 2006 and 2018, 156 patients (132 male; mean age, 62 y; age range, 33-81 y) underwent SVC stent placement for malignant obstructions through upper-limb venous access with 1 of 3 types of nitinol stent: 1 venous-dedicated (Sinus-XL stent) and 2 non-venous-dedicated (E-Luminexx Vascular Stent and Protégé GPS). Cases of common femoral vein access or non-nitinol stents were excluded from further analysis. The mean duration of follow-up was 8 mo.
RESULTS:
Technical success was achieved in 99.3% of cases. One patient died during the procedure as a result of cardiac tamponade. Balloon predilation was performed in 10 patients and postdilation in 126. Mean procedural time was 34.4 min (range, 18-80 min). Overall survival rates were 92.3%, 57.3%, and 26.8%, and overall primary patency rates were 94.5%, 84.8% and 79.6%, at 1, 6, and 12 mo, respectively. There were no statistically significant differences in primary patency rates between venous- and non-venous-dedicated stents or among different Stanford SVCS grading groups (P > .05).
CONCLUSIONS:
SVC stent placement through an upper-limb approach is a safe, fast, and effective technique. There is no evident benefit of venous-dedicated vs non-venous-dedicated stents in the treatment of malignant SVCS.
AuthorsNikolas Matthaiou, Nikolaos Galanakis, Elias Kehagias, Nikolaos Kontopodis, Stavros Charalambous, Nelly Kholcheva, Konstantinos Tsetis, Dimitrios Mavroudis, Dimitrios Tsetis
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 31 Issue 12 Pg. 2066-2072 (Dec 2020) ISSN: 1535-7732 [Electronic] United States
PMID33127247 (Publication Type: Comparative Study, Journal Article, Observational Study)
CopyrightCopyright © 2020 SIR. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Alloys
  • nitinol
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Alloys
  • Angioplasty, Balloon (adverse effects, instrumentation)
  • Catheterization, Peripheral (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms (complications, diagnostic imaging)
  • Prosthesis Design
  • Registries
  • Retrospective Studies
  • Stents
  • Superior Vena Cava Syndrome (diagnostic imaging, etiology, physiopathology, therapy)
  • Time Factors
  • Treatment Outcome
  • Upper Extremity (blood supply)
  • Vascular Patency
  • Vena Cava, Superior (diagnostic imaging, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: